Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Carlomaurizio Montecucco and Serena Bugatti.
Carlomaurizio Montecucco
Connection Strength
3.718
Serena Bugatti
  1. Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis. Ann Rheum Dis. 2021 12; 80(12):1635-1638.
    View in: PubMed
    Score: 0.953
  2. Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'. Ann Rheum Dis. 2021 10; 80(10):e156.
    View in: PubMed
    Score: 0.942
  3. Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline. RMD Open. 2020 10; 6(3).
    View in: PubMed
    Score: 0.906
  4. Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19. Ann Rheum Dis. 2021 09; 80(9):1242-1243.
    View in: PubMed
    Score: 0.237
  5. Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis. Arthritis Res Ther. 2020 12 30; 22(1):290.
    View in: PubMed
    Score: 0.230
  6. A "Window of Therapeutic Opportunity" for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019. Front Immunol. 2020; 11:572635.
    View in: PubMed
    Score: 0.227
  7. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis. 2020 Aug 04.
    View in: PubMed
    Score: 0.224
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.